Cargando…

CD137L, a driver of harmful inflammation in the nervous system

Detalles Bibliográficos
Autores principales:	Wong, Hiu Yi, Chan, Amanda C.Y., Mak, Anselm, Schwarz, Herbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360085/ https://www.ncbi.nlm.nih.gov/pubmed/37282461 http://dx.doi.org/10.4103/1673-5374.371357

Ejemplares similares

The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus
por: Mak, Anselm, et al.
Publicado: (2019)

Deletion of CD137 Ligand Exacerbates Renal and Cutaneous but Alleviates Cerebral Manifestations in Lupus
por: Mak, Anselm, et al.
Publicado: (2019)

Identification of CD137-Expressing B Cells in Multiple Sclerosis Which Secrete IL-6 Upon Engagement by CD137 Ligand
por: Wong, Hiu Yi, et al.
Publicado: (2020)

Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells
por: Rajendran, Sakthi, et al.
Publicado: (2019)

CD137-CD137 Ligand Interactions in Inflammation
por: Kwon, Byungsuk
Publicado: (2009)

Soluble CD137 as a potential biomarker for severe COVID-19
por: Marques, Mariana de Oliveira, et al.
Publicado: (2022)

CD137 Facilitates the Resolution of Acute DSS-Induced Colonic Inflammation in Mice
por: Martínez Gómez, Julia M., et al.
Publicado: (2013)

CD137L-DCs, Potent Immune-Stimulators—History, Characteristics, and Perspectives
por: Zeng, Qun, et al.
Publicado: (2019)

Increased Akt-Driven Glycolysis Is the Basis for the Higher Potency of CD137L-DCs
por: Zeng, Qun, et al.
Publicado: (2019)

Correction: CD137 Facilitates the Resolution of Acute DSS-Induced Colonic Inflammation in Mice
por: Martínez Gómez, Julia M., et al.
Publicado: (2014)

Regulatory T Cells Inhibit T Cell Activity by Downregulating CD137 Ligand via CD137 Trogocytosis
por: Luu, Khang, et al.
Publicado: (2021)

Ectopic CD137 expression by rhabdomyosarcoma provides selection advantages but allows immunotherapeutic targeting
por: Lee, Kang Yi, et al.
Publicado: (2021)

Transcriptional and functional characterization of CD137L-dendritic cells identifies a novel dendritic cell phenotype
por: Harfuddin, Zulkarnain, et al.
Publicado: (2016)

CD40L/CD40 bidirectional signaling is a major regulator of neuronal morphology in the developing nervous system
por: Carriba, Paulina, et al.
Publicado: (2021)

Vascular inflammation in the central nervous system
por: Guo, Xinying, et al.
Publicado: (2022)

Is CD137 Ligand (CD137L) Signaling a Fine Tuner of Immune Responses?
por: Kwon, Byungsuk
Publicado: (2015)

Species Difference of CD137 Ligand Signaling in Human and Murine Monocytes
por: Tang, Qianqiao, et al.
Publicado: (2011)

Regulation of Granulocyte and Macrophage Populations of Murine Bone Marrow Cells by G-CSF and CD137 Protein
por: Jiang, Dongsheng, et al.
Publicado: (2010)

CD137 ligand reverse signaling skews hematopoiesis towards myelopoiesis during aging
por: Tang, Qianqiao, et al.
Publicado: (2013)

CD137-CD137L Interaction Regulates Atherosclerosis via Cyclophilin A in Apolipoprotein E-Deficient Mice
por: Li, Yuefeng, et al.
Publicado: (2014)

Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism
por: Labiano, Sara, et al.
Publicado: (2014)

Screening for Chronic Kidney Disease: Preventing Harm or Harming the Healthy?
por: Taal, Maarten W.
Publicado: (2012)

Ectopic CD137 expression facilitates the escape of Hodgkin and Reed-Sternberg cells from immunosurveillance
por: Pang, Wan Lu, et al.
Publicado: (2013)

Gambling harm prevention and harm reduction in online environments: a call for action
por: Marionneau, Virve, et al.
Publicado: (2023)

Chronic inflammation: is it the driver or is it paving the road for malignant transformation?
por: Afrasiabi, Kambiz, et al.
Publicado: (2015)

Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
por: Glez-Vaz, Javier, et al.
Publicado: (2022)

Regulation of Inflammation by Bidirectional Signaling through CD137 and Its Ligand
por: Kwon, Byungsuk
Publicado: (2012)

Persistent Inpatient Harm: the Unremitting Challenge of Patient Safety
por: Adashi, Eli Y., et al.
Publicado: (2022)

Correction: Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
Publicado: (2023)

Inhibition of Proliferation and Induction of Apoptosis in Multiple Myeloma Cell Lines by CD137 Ligand Signaling
por: Gullo, Charles, et al.
Publicado: (2010)

CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species
por: Yeo, Yee Andy, et al.
Publicado: (2012)

The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity
por: Choi, Beom K., et al.
Publicado: (2020)

Increased Soluble CD137 Levels and CD4+ T‐Cell‐Associated Expression of CD137 in Acute Atherothrombotic Stroke
por: He, Yang, et al.
Publicado: (2018)

Delivery of therapeutics to posterior eye segment: cell-encapsulating systems
por: Wong, Francisca S.Y., et al.
Publicado: (2017)

Harm or protection? The adaptive function of tick toxins
por: Apari, Péter, et al.
Publicado: (2020)

Electronic Cigarette Use during Pregnancy: Is It Harmful?
por: Vilcassim, M. J. Ruzmyn, et al.
Publicado: (2023)

The Roles of CD137 Signaling in Atherosclerosis
por: Jung, In-Hyuk, et al.
Publicado: (2016)

Development of Obesity: The Driver and the Passenger
por: Kopp, Wolfgang
Publicado: (2020)

Strategies for an effective tobacco harm reduction policy in Indonesia
por: Nurwidya, Fariz, et al.
Publicado: (2014)

Publication reform to safeguard wildlife from researcher harm
por: Field, Kate A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_toiqb85j41iuvcjqagju534k5g